Genenta Science S.p.A. (GNTA) vs RCM Technologies (RCMT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
RCM Technologies (RCMT) has outperformed Genenta Science S.p.A. (GNTA) over the past year, gaining 71.9% versus a loss of 78.4%. RCM Technologies is the larger company by market cap ($297.6 million vs $34.2 million), about 8.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNTA | RCMT |
|---|---|---|
| Share price | $0.7101 | $41.85 |
| Market cap | $34.24M | $297.59M |
| 1-day change | -5.95% | +1.09% |
| YTD return | -52.34% | +104.65% |
| 1-year return | -78.35% | +71.94% |
| 5-year return | — | +598.66% |
| P/E ratio (TTM) | — | 18.20 |
| Forward P/E | — | 12.82 |
| EPS (TTM) | $-0.37 | $2.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.00 | $43.68 |
| 52-week low | $0.55 | $17.26 |
| Distance from 52-week high | -92.90% | -4.19% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +7.53% |
| Average volume | 61.46K | 70.12K |
| Shares outstanding | 48.22M | 7.11M |
| Employees | 9 | 4,930 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCM Technologies is about 8.7 times larger than Genenta Science S.p.A. by market value ($297.59M vs $34.24M).
- RCMT has outperformed GNTA by 150.3 percentage points over the past year.
- The two companies sit in different sectors: Genenta Science S.p.A. in Health Care and RCM Technologies in Consumer Discretionary.
About Genenta Science S.p.A.
GNTA stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 9 employees
About RCM Technologies
RCMT stock →RCM Technologies, Inc. engages in the provision of business and technology solutions in the United States, Canada, Puerto Rico, Europe, and Philippines.
Consumer Discretionary · Professional Services · 4,930 employees
GNTA vs RCMT FAQ
Which is bigger, Genenta Science S.p.A. or RCM Technologies?
RCM Technologies (RCMT) is larger, with a market capitalization of $297.59M compared with $34.24M for Genenta Science S.p.A. (GNTA).
Which stock has performed better over the past year, GNTA or RCMT?
RCMT returned +71.94% over the past 12 months, compared with -78.35% for GNTA (price return, excluding dividends). Past performance does not predict future results.
Are Genenta Science S.p.A. and RCM Technologies in the same industry?
No. Genenta Science S.p.A. is in the Health Care sector, while RCM Technologies is in Consumer Discretionary.